Sebastian M. Schellong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sebastian M. Schellong has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Benjamin Schmidt
Zentrum für Gefässmedizin, Bereich Angiologie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden
2 shared publicationsB. Schmidt
Division of Angiology, Medical Clinic III, University Hospital Carl Gustav Carus, Technical University Dresden, Germany
1 shared publicationBenjamin A. Schmidt
1 shared publicationDetlev Ockert
Klinik für Viszeral-, Thorax- und Gefäßchirugie, Universitätsklinik Carl Gustav Carus, Medizinische Fakultät der TU Dresden DE
1 shared publicationE Altmann
Medical Clinic II, City Clinic, Friedrichstr. 41, D-01067 Dresden, Germany
1 shared publicationG Rudofsky
Angiological Clinic, University Clinic of Essen, Hufelandstr. 3, D-45147 Essen, Germany
1 shared publication
Latest Publications
- 1 September 2004
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 10 (5) , 350-355
Complete compression ultrasound for the diagnosis of venous thromboembolism
Since its first appearance in the 1980s, venous ultrasound has increasingly gained interest of both clinicians and researchers. However, a majority of authors currently are convinced that venous ultrasound has inherent limitations that preclude it from safely ruling out distal deep vein thrombosis (DVT) in symptomatic patients and from detecting proximal and distal DVT accurately in asymptomatic patients. The aim of this review is to present recent lines of evidence indicating that venous ultrasound has developed beyond these limitations. The major development does not arise from technical progress of imaging but from standardizing the examination procedure. The most efficient protocols now focus on B-mode sonography only but extend the examination to the paired deep calf veins and the calf muscle veins. For such an examination protocol, the term complete compression ultrasound (CCUS) has been coined. Interobserver variability of CCUS resembles that of venography, as do the technical failure rates. By means of a CCUS protocol, the diagnostic work-up of patients with suspected DVT can be simplified significantly. Studies in asymptomatic patients indicate that CCUS has the potential to generate valid data in prevalence and incidence studies and in intervention trials. Complete compression ultrasound protocols are ready for implementation into clinical practice for diagnosing patients with symptomatic DVT. Research has already benefited from CCUS and benefits further with an increasing number of CCUS-driven trial designs. However, the value of a CCUS protocol critically depends on sound training and on strict compliance with all its details.
- 1 September 2004
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 10 (5) , 350-355
Complete compression ultrasound for the diagnosis of venous thromboembolism
Since its first appearance in the 1980s, venous ultrasound has increasingly gained interest of both clinicians and researchers. However, a majority of authors currently are convinced that venous ultrasound has inherent limitations that preclude it from safely ruling out distal deep vein thrombosis (DVT) in symptomatic patients and from detecting proximal and distal DVT accurately in asymptomatic patients. The aim of this review is to present recent lines of evidence indicating that venous ultrasound has developed beyond these limitations. The major development does not arise from technical progress of imaging but from standardizing the examination procedure. The most efficient protocols now focus on B-mode sonography only but extend the examination to the paired deep calf veins and the calf muscle veins. For such an examination protocol, the term complete compression ultrasound (CCUS) has been coined. Interobserver variability of CCUS resembles that of venography, as do the technical failure rates. By means of a CCUS protocol, the diagnostic work-up of patients with suspected DVT can be simplified significantly. Studies in asymptomatic patients indicate that CCUS has the potential to generate valid data in prevalence and incidence studies and in intervention trials. Complete compression ultrasound protocols are ready for implementation into clinical practice for diagnosing patients with symptomatic DVT. Research has already benefited from CCUS and benefits further with an increasing number of CCUS-driven trial designs. However, the value of a CCUS protocol critically depends on sound training and on strict compliance with all its details.
- 1 December 2003
- Published by S. Karger AG in Respiration
- Vol. 70 (6) , 559-568
New Therapeutic Approaches in Pulmonary Embolism
Pulmonary embolism as a part of venous thromboembolic disease has a broad spectrum of clinical presentations from minimal disease to life-threatening right heart failure. Therapy has to be guided by the risk associated with the individual clinical state of the patient. As long as hemodynamics are entirely stable, anticoagulation is given in order to prevent early or late recurrence, thereby allowing for endogeneous thrombolysis and recovery. In hemodynamically instable patients, i.e. patients under cardiopulmonary resuscitation or in shock, there is the need for a rapid reduction of thrombus mass in order to restore right ventricular function. Systemic thrombolysis is the most feasible modality to reduce the thrombus burden of the pulmonary circulation in the short term. For hemodynamically stable patients with right ventricular dysfunction as assessed by echocardiography, there is still some controversy as to whether thrombolysis improves the long-term outcome. At the least, thrombolysis may positively modify the short-term course of acute disease in patients with an extremely low risk of bleeding. When the acute phase has been overcome, secondary prophylaxis with vitamin K antagonists has to be given. The duration of secondary prophylaxis requires an individual assessment of both the risk of recurrence and the risk of bleeding. In the near future, new anticoagulant drugs such as direct thrombin and factor Xa inhibitors will offer new treatment modalities for the acute phase as well as for secondary prophylaxis.
- 1 December 2003
- Published by S. Karger AG in Respiration
- Vol. 70 (6) , 559-568
New Therapeutic Approaches in Pulmonary Embolism
Pulmonary embolism as a part of venous thromboembolic disease has a broad spectrum of clinical presentations from minimal disease to life-threatening right heart failure. Therapy has to be guided by the risk associated with the individual clinical state of the patient. As long as hemodynamics are entirely stable, anticoagulation is given in order to prevent early or late recurrence, thereby allowing for endogeneous thrombolysis and recovery. In hemodynamically instable patients, i.e. patients under cardiopulmonary resuscitation or in shock, there is the need for a rapid reduction of thrombus mass in order to restore right ventricular function. Systemic thrombolysis is the most feasible modality to reduce the thrombus burden of the pulmonary circulation in the short term. For hemodynamically stable patients with right ventricular dysfunction as assessed by echocardiography, there is still some controversy as to whether thrombolysis improves the long-term outcome. At the least, thrombolysis may positively modify the short-term course of acute disease in patients with an extremely low risk of bleeding. When the acute phase has been overcome, secondary prophylaxis with vitamin K antagonists has to be given. The duration of secondary prophylaxis requires an individual assessment of both the risk of recurrence and the risk of bleeding. In the near future, new anticoagulant drugs such as direct thrombin and factor Xa inhibitors will offer new treatment modalities for the acute phase as well as for secondary prophylaxis.
- 1 March 2003
- Published by Springer Nature in Medizinische Klinik
- Vol. 98 (3) , 133-139
Thrombophile Störungen bei venöser Thromboembolie aus klinischer Perspektive
Hintergrund: Bei der Behandlung venöser Thromboembolien ist der Einfluss thrombophiler Störungen auf das Rezidivrisiko zu kalkulieren und gegen Risiken einer Antikoagulanzientherapie abzuwägen. Da die heute bekannten Thrombophilieparameter diesbezüglich unterschiedlichen Stellenwert haben, sollte sich eine rationelle Diagnostik eng an der Erwartung therapeutischer Konsequenzen orientieren. Die klinische Herangehensweise an thrombophile Störungen ist deshalb auf die Kenntnis der heute vorliegenden Daten zur Risikostratifizierung bei Thrombosepatienten angewiesen. Methodik: Unter dem Blickwinkel der praktischen Umsetzung wird die aktuelle Literatur zu thrombophilen Störungen analysiert. In Gegenüberstellung der Risiken von Erkrankung und Therapie und unter Berücksichtigung validierter Therapien werden aktuelle Behandlungsrichtlinien dargestellt. Es werden Empfehlungen zu einer rationellen Diagnostik gegeben, die sich an potentiell abzuleitenden Therapien orientiert. Schlussfolgerung: Das Rezidivrisiko nach klassisch getriggerten venösen Thromboembolien ist so gering, dass eine Antikoagulationsdauer bis zu 6 Monaten ausreichend ist. Idiopathische Thromboembolien oder Thrombosen ungewöhnlicher Lokalisation sind mit einem höheren Rezidivrisiko vergesellschaftet, da häufiger thrombophile Störungen zugrunde liegen. Hier besteht die Indikation zur Bestimmung thrombophiler Faktoren (deren Relevanz im Einzelnen diskutiert wird); eine längere Antikoagulationszeit ist indiziert (1 Jahr, bei schwerer Thrombophilie mehrere Jahre). Rezidivierende venöse Thromboembolien sollten für 4 Jahre behandelt werden, länger bei unproblematischer Führung der Antikoagulation. Background: Treatment of venous thromboembolism should consider the influence of thrombophilic disorders on the risk of recurrence. Diagnostic tests should be guided by their expected relevance to therapy. A competent and straightforward clinical approach to venous thromboembolism requires knowledge of the current data regarding stratification of risk of recurrence in thrombophilic patients. Methods: Focusing on clinical management, the current literature on thrombophilia is analyzed. Recommendations are given taking into account the risk of first and recurrent thromboembolism, the bleeding risk under anticoagulation, and validated therapy strategies. A rational diagnostic approach in the light of potential therapies is suggested. Conclusion: The recurrence risk after triggered venous thromboembolism is low, and anticoagulation does not need to be extended beyond 6 months. Idiopathic or thromboembolism in unusual locations is associated with a higher recurrence risk since underlying thrombophilia is more common in these patients. These cases merit laboratory screening for thrombophilic factors (whose relevance is discussed), and extended anticoagulation is indicated (1 year; in severe thrombophilia several years). In recurrent venous thromboembolism anticoagulation is ideally continued for 4 years, or longer in the absence of complications.
- 1 March 2003
- Published by Springer Nature in Medizinische Klinik
- Vol. 98 (3) , 133-139
Thrombophile Störungen bei venöser Thromboembolie aus klinischer Perspektive
Hintergrund: Bei der Behandlung venöser Thromboembolien ist der Einfluss thrombophiler Störungen auf das Rezidivrisiko zu kalkulieren und gegen Risiken einer Antikoagulanzientherapie abzuwägen. Da die heute bekannten Thrombophilieparameter diesbezüglich unterschiedlichen Stellenwert haben, sollte sich eine rationelle Diagnostik eng an der Erwartung therapeutischer Konsequenzen orientieren. Die klinische Herangehensweise an thrombophile Störungen ist deshalb auf die Kenntnis der heute vorliegenden Daten zur Risikostratifizierung bei Thrombosepatienten angewiesen. Methodik: Unter dem Blickwinkel der praktischen Umsetzung wird die aktuelle Literatur zu thrombophilen Störungen analysiert. In Gegenüberstellung der Risiken von Erkrankung und Therapie und unter Berücksichtigung validierter Therapien werden aktuelle Behandlungsrichtlinien dargestellt. Es werden Empfehlungen zu einer rationellen Diagnostik gegeben, die sich an potentiell abzuleitenden Therapien orientiert. Schlussfolgerung: Das Rezidivrisiko nach klassisch getriggerten venösen Thromboembolien ist so gering, dass eine Antikoagulationsdauer bis zu 6 Monaten ausreichend ist. Idiopathische Thromboembolien oder Thrombosen ungewöhnlicher Lokalisation sind mit einem höheren Rezidivrisiko vergesellschaftet, da häufiger thrombophile Störungen zugrunde liegen. Hier besteht die Indikation zur Bestimmung thrombophiler Faktoren (deren Relevanz im Einzelnen diskutiert wird); eine längere Antikoagulationszeit ist indiziert (1 Jahr, bei schwerer Thrombophilie mehrere Jahre). Rezidivierende venöse Thromboembolien sollten für 4 Jahre behandelt werden, länger bei unproblematischer Führung der Antikoagulation. Background: Treatment of venous thromboembolism should consider the influence of thrombophilic disorders on the risk of recurrence. Diagnostic tests should be guided by their expected relevance to therapy. A competent and straightforward clinical approach to venous thromboembolism requires knowledge of the current data regarding stratification of risk of recurrence in thrombophilic patients. Methods: Focusing on clinical management, the current literature on thrombophilia is analyzed. Recommendations are given taking into account the risk of first and recurrent thromboembolism, the bleeding risk under anticoagulation, and validated therapy strategies. A rational diagnostic approach in the light of potential therapies is suggested. Conclusion: The recurrence risk after triggered venous thromboembolism is low, and anticoagulation does not need to be extended beyond 6 months. Idiopathic or thromboembolism in unusual locations is associated with a higher recurrence risk since underlying thrombophilia is more common in these patients. These cases merit laboratory screening for thrombophilic factors (whose relevance is discussed), and extended anticoagulation is indicated (1 year; in severe thrombophilia several years). In recurrent venous thromboembolism anticoagulation is ideally continued for 4 years, or longer in the absence of complications.
- 1 January 2003
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 89 (02) , 228-234
Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis
Summary: Noninvasive diagnosis of deep vein thrombosis (DVT) is based on ultrasound examination of the leg veins, usually restricted to only compression of the proximal veins (CUS). Patients with negative CUS findings require a second examination or a combination with other tests, which impairs clinical efficiency. In this prospective outcome study, 1646 consecutive patients with clinically suspected DVT were examined once by a standardized protocol of complete compression ultrasound comprising all proximal and distal veins (CCUS) as the only diagnostic test. The examination was equivocal in 15 patients (1% technical failure rate). Another 366 patients (22%) were tested positive for proximal DVT, distal DVT, muscle vein thrombosis, or phlebitis. Of 1265 patients in whom CCUS findings were negative, 242 met exclusion criteria for follow-up (age <18, life expectancy <3 months, other reasons for anticoagulation, postthrombotic lesions of the leg veins, or lack of informed consent). During the 3 months of follow-up, three of 1023 patients with negative CCUS findings experienced a symptomatic venous thromboembolic event (0.3% [95% CI 0.1%-0.8%]). We conclude that the CCUS protocol has a low technical failure rate and is safe with respect to excluding DVT, thereby reducing the diagnostic workup of patients with suspected DVT to a single ultrasound examination.
- 1 January 2003
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 89 (02) , 228-234
Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis
Summary: Noninvasive diagnosis of deep vein thrombosis (DVT) is based on ultrasound examination of the leg veins, usually restricted to only compression of the proximal veins (CUS). Patients with negative CUS findings require a second examination or a combination with other tests, which impairs clinical efficiency. In this prospective outcome study, 1646 consecutive patients with clinically suspected DVT were examined once by a standardized protocol of complete compression ultrasound comprising all proximal and distal veins (CCUS) as the only diagnostic test. The examination was equivocal in 15 patients (1% technical failure rate). Another 366 patients (22%) were tested positive for proximal DVT, distal DVT, muscle vein thrombosis, or phlebitis. Of 1265 patients in whom CCUS findings were negative, 242 met exclusion criteria for follow-up (age <18, life expectancy <3 months, other reasons for anticoagulation, postthrombotic lesions of the leg veins, or lack of informed consent). During the 3 months of follow-up, three of 1023 patients with negative CCUS findings experienced a symptomatic venous thromboembolic event (0.3% [95% CI 0.1%-0.8%]). We conclude that the CCUS protocol has a low technical failure rate and is safe with respect to excluding DVT, thereby reducing the diagnostic workup of patients with suspected DVT to a single ultrasound examination.
- 1 November 2001
- Published by Hogrefe Publishing Group in Vasa
- Vol. 30 (4) , 253-257
Die vollständige Kompressionssonographie zur Diagnose der proximalen und distalen Venenthrombose – eine retrospektive Untersuchung
Background: Compression ultrasound is considered the preferred test for the diagnosis of deep vein thrombosis of the leg (DVT). Since sensitivity for distal thrombosis is low additional tests are required. We developed a protocol of complete compression ultrasound of all venous segments of the leg (CCUS). A retrospective outcome study was performed to get an estimate of the rate of indeterminate results necessitating repeated testing as well as for the clinical safety of CCUS in a cohort of consecutive, unselected patients. Patients and methods: Case records of all patients referred for clinical suspicion of deep vein thrombosis within a three months period were reviewed. Patients with negative CCUS were followed directly or via the general practitioner in order to know whether an episode of venous thromboembolism had been documented since the initial CCUS. Results: 132 inpatients and 154 outpatients were identified. Clinical probability was high in 50 patients, medium in 142, and low in 94. The first CCUS was negative in 209 cases. Five patients (1,8%) had repeated CCUS within the next 7 days because of incomplete visualisation of the distal veins and turned out to be negative as well. Of all 214 patients with negative CCUS a clinical follow-up information was obtained after 168 ± 25 days. Five patients had died, none due to pulmonary embolism. In two patients deep vein thrombosis had been documented (0,9% [95% CI: 0,1–3,3%]) 148 and 172 days after CCUS, respectively. Conclusion: CCUS for diagnosis of DVT needs to be repeated in very few cases only. Clinical safety seems to fall into the same range as with combined algorithms and should be tested in a prospective design. Patients with medium and high probability showed a very low incidence of DVT within three months following CCUS; therefore, they may be included in a prospective outcome study.
- 1 November 2001
- Published by Hogrefe Publishing Group in Vasa
- Vol. 30 (4) , 253-257
Die vollständige Kompressionssonographie zur Diagnose der proximalen und distalen Venenthrombose – eine retrospektive Untersuchung
Background: Compression ultrasound is considered the preferred test for the diagnosis of deep vein thrombosis of the leg (DVT). Since sensitivity for distal thrombosis is low additional tests are required. We developed a protocol of complete compression ultrasound of all venous segments of the leg (CCUS). A retrospective outcome study was performed to get an estimate of the rate of indeterminate results necessitating repeated testing as well as for the clinical safety of CCUS in a cohort of consecutive, unselected patients. Patients and methods: Case records of all patients referred for clinical suspicion of deep vein thrombosis within a three months period were reviewed. Patients with negative CCUS were followed directly or via the general practitioner in order to know whether an episode of venous thromboembolism had been documented since the initial CCUS. Results: 132 inpatients and 154 outpatients were identified. Clinical probability was high in 50 patients, medium in 142, and low in 94. The first CCUS was negative in 209 cases. Five patients (1,8%) had repeated CCUS within the next 7 days because of incomplete visualisation of the distal veins and turned out to be negative as well. Of all 214 patients with negative CCUS a clinical follow-up information was obtained after 168 ± 25 days. Five patients had died, none due to pulmonary embolism. In two patients deep vein thrombosis had been documented (0,9% [95% CI: 0,1–3,3%]) 148 and 172 days after CCUS, respectively. Conclusion: CCUS for diagnosis of DVT needs to be repeated in very few cases only. Clinical safety seems to fall into the same range as with combined algorithms and should be tested in a prospective design. Patients with medium and high probability showed a very low incidence of DVT within three months following CCUS; therefore, they may be included in a prospective outcome study.